SEVERANCE AND CHANGE OF CONTROL AGREEMENTSeverance and Change of Control Agreement • February 24th, 2025 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
This Severance and Change of Control Agreement (the “Agreement”) is made and entered into on February 24, 2025, by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and Samraat S. Raha (“Employee”).
SEVERANCE AND CHANGE OF CONTROL AGREEMENTSeverance and Change of Control Agreement • February 24th, 2025 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
This Severance and Change of Control Agreement (the “Agreement”) is made and entered into on February 24, 2025, by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and Mark S. Verratti (“Employee”).
SEVERANCE AND CHANGE OF CONTROL AGREEMENTSeverance and Change of Control Agreement • February 28th, 2024 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
This Severance and Change of Control Agreement (the “Agreement”) is made and entered into on December 11, 2023 (the “Effective Date”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and Samraat S. Raha (“Employee”).